Advertisement
Advertisement
PLSE
Pulse Biosciences, Inc Common Stock (DE)
19.08
USDSponsored
-0.51
-2.60%
May 08, 15:58 UTC -4
Closed
After-Market
19.09
+0.01
+0.05%
PLSE Earnings Reports
Positive Surprise Ratio
PLSE beat 10 of 23 last estimates.
43%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$652.80K
/-$0.34
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/+70.00%
Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue
On May 07, 2026, PLSE reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.32 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 408.00 thousand, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.34 USD, with revenue projected to reach 652.80 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Artivion, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+59.68%
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
Pacific Biosciences of California, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.73%
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
EDAP TMS SA
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-25.59%
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
LENSAR, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
$0.18
Actual
$0.00
Surprise
-100.00%
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
FAQ
What were Pulse Biosciences, Inc Common Stock (DE)'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Pulse Biosciences, Inc Common Stock (DE) reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Pulse Biosciences, Inc Common Stock (DE)'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Pulse Biosciences, Inc Common Stock (DE) expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Pulse Biosciences, Inc Common Stock (DE)'s next earnings report?
Based on 3
analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.34 and revenue of $652.80K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement